Header Logo

Connection

Alan Go to Heart Failure

Back to Details
This is a "connection" page, showing publications Alan Go has written about Heart Failure.
Alan Go
Connection Strength
12.606
Heart Failure
  1. Approach to Multimorbidity Burden Classification and Outcomes in Older Adults With Heart Failure. Med Care. 2023 05 01; 61(5):268-278.
    View in: PubMed
    Score: 0.585
  2. Predicting short-term outcomes after transcatheter aortic valve replacement for aortic stenosis. Am Heart J. 2023 02; 256:60-72.
    View in: PubMed
    Score: 0.571
  3. Adverse Events After Initiating Angiotensin-Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Therapy in Individuals with Heart Failure and Multimorbidity. Am J Med. 2022 12; 135(12):1468-1477.
    View in: PubMed
    Score: 0.564
  4. Effect of Medically Tailored Meals on Clinical Outcomes in Recently Hospitalized High-Risk Adults. Med Care. 2022 10 01; 60(10):750-758.
    View in: PubMed
    Score: 0.562
  5. Analysis of Worsening Heart Failure Events in an Integrated Health Care System. J Am Coll Cardiol. 2022 Jul 12; 80(2):111-122.
    View in: PubMed
    Score: 0.558
  6. A Natural Language Processing-Based Approach for Identifying Hospitalizations for Worsening Heart Failure Within an Integrated Health Care Delivery System. JAMA Netw Open. 2021 11 01; 4(11):e2135152.
    View in: PubMed
    Score: 0.532
  7. Noncardiac-Related Morbidity, Mobility Limitation, and Outcomes in Older Adults With Heart Failure. J Gerontol A Biol Sci Med Sci. 2020 09 25; 75(10):1981-1988.
    View in: PubMed
    Score: 0.493
  8. The Heart Failure Readmission Intervention by Variable Early Follow-up (THRIVE) Study: A Pragmatic Randomized Trial. Circ Cardiovasc Qual Outcomes. 2020 10; 13(10):e006553.
    View in: PubMed
    Score: 0.493
  9. Advancing Research on the Complex Interrelations Between Atrial Fibrillation and Heart Failure: A Report From a US National Heart, Lung, and Blood Institute Virtual Workshop. Circulation. 2020 06 09; 141(23):1915-1926.
    View in: PubMed
    Score: 0.483
  10. Short-Term Outcomes and Factors Associated With Adverse Events Among Adults Discharged From the Emergency Department After Treatment for Acute Heart Failure. Circ Heart Fail. 2017 Dec; 10(12).
    View in: PubMed
    Score: 0.405
  11. Treatment Effectiveness in Heart Failure with Comorbidity: Lung Disease and Kidney Disease. J Am Geriatr Soc. 2017 Dec; 65(12):2610-2618.
    View in: PubMed
    Score: 0.399
  12. Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators. Heart. 2017 04; 103(7):529-537.
    View in: PubMed
    Score: 0.375
  13. Post-discharge Follow-up Characteristics Associated With 30-Day Readmission After Heart Failure Hospitalization. Med Care. 2016 Apr; 54(4):365-72.
    View in: PubMed
    Score: 0.361
  14. Hospital-level variation in use of cardiovascular testing for adults with incident heart failure: findings from the cardiovascular research network heart failure study. JACC Cardiovasc Imaging. 2014 Jul; 7(7):690-700.
    View in: PubMed
    Score: 0.319
  15. Risk factors for adverse outcomes by left ventricular ejection fraction in a contemporary heart failure population. Circ Heart Fail. 2013 Jul; 6(4):635-46.
    View in: PubMed
    Score: 0.296
  16. Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE Study. Circ Cardiovasc Qual Outcomes. 2013 May 01; 6(3):333-42.
    View in: PubMed
    Score: 0.295
  17. Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction. Am J Med. 2013 May; 126(5):393-400.
    View in: PubMed
    Score: 0.292
  18. Effectiveness of ß-blockers in heart failure with left ventricular systolic dysfunction and chronic kidney disease. J Card Fail. 2013 Mar; 19(3):176-82.
    View in: PubMed
    Score: 0.292
  19. Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice. Arch Intern Med. 2008 Dec 08; 168(22):2415-21.
    View in: PubMed
    Score: 0.218
  20. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure. Am J Cardiol. 2007 Aug 15; 100(4):690-6.
    View in: PubMed
    Score: 0.197
  21. Statin therapy and risks for death and hospitalization in chronic heart failure. JAMA. 2006 Nov 01; 296(17):2105-11.
    View in: PubMed
    Score: 0.188
  22. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation. 2006 Jun 13; 113(23):2713-23.
    View in: PubMed
    Score: 0.183
  23. Clinical and research applications of natural language processing for heart failure. Heart Fail Rev. 2025 Mar; 30(2):407-415.
    View in: PubMed
    Score: 0.165
  24. Rule-based natural language processing to examine variation in worsening heart failure hospitalizations by age, sex, race and ethnicity, and left ventricular ejection fraction. Am Heart J. 2024 Dec; 278:117-126.
    View in: PubMed
    Score: 0.162
  25. Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study. J Am Coll Cardiol. 2004 Feb 04; 43(3):429-35.
    View in: PubMed
    Score: 0.156
  26. Developing Clinical Risk Prediction Models for Worsening Heart Failure Events and Death by Left Ventricular Ejection Fraction. J Am Heart Assoc. 2023 10 03; 12(19):e029736.
    View in: PubMed
    Score: 0.152
  27. The association between changes in echocardiography and risk of heart failure hospitalizations and death in adults with chronic kidney disease. Sci Rep. 2023 05 31; 13(1):8863.
    View in: PubMed
    Score: 0.148
  28. Variation in Heart Failure Risk by HIV Severity and Sex in People With HIV Infection. J Acquir Immune Defic Syndr. 2022 10 01; 91(2):175-181.
    View in: PubMed
    Score: 0.142
  29. Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical Events After Hospitalization: Findings From the ASSESS-AKI and ARID Studies. Am J Kidney Dis. 2023 02; 81(2):190-200.
    View in: PubMed
    Score: 0.141
  30. Food security, diet quality, nutritional knowledge, and attitudes towards research in adults with heart failure during the COVID-19 pandemic. Clin Cardiol. 2022 Feb; 45(2):180-188.
    View in: PubMed
    Score: 0.135
  31. Physician adjudication of angioedema diagnosis codes in a population of patients with heart failure prescribed angiotensin-converting enzyme inhibitor therapy. Pharmacoepidemiol Drug Saf. 2021 12; 30(12):1630-1634.
    View in: PubMed
    Score: 0.132
  32. Sex Differences in Cardiovascular Outcomes in CKD: Findings From the CRIC Study. Am J Kidney Dis. 2021 08; 78(2):200-209.e1.
    View in: PubMed
    Score: 0.128
  33. Association Between Kidney Clearance of Secretory Solutes and Cardiovascular Events: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2021 08; 78(2):226-235.e1.
    View in: PubMed
    Score: 0.126
  34. Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2021 06; 77(6):907-919.
    View in: PubMed
    Score: 0.125
  35. Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure. J Am Heart Assoc. 2020 07 07; 9(13):e014385.
    View in: PubMed
    Score: 0.121
  36. A reduced transferrin saturation is independently associated with excess morbidity and mortality in older adults with heart failure and incident anemia. Int J Cardiol. 2020 06 15; 309:95-99.
    View in: PubMed
    Score: 0.119
  37. A systematic review of the effects of physician specialty on the treatment of coronary disease and heart failure in the United States. Am J Med. 2000 Feb 15; 108(3):216-26.
    View in: PubMed
    Score: 0.118
  38. Cardiac Biomarkers and Risk of Incident Heart Failure in Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study. J Am Heart Assoc. 2019 11 05; 8(21):e012336.
    View in: PubMed
    Score: 0.116
  39. Burden and Outcomes of Heart Failure Hospitalizations in Adults With Chronic Kidney Disease. J Am Coll Cardiol. 2019 06 04; 73(21):2691-2700.
    View in: PubMed
    Score: 0.112
  40. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators. J Am Heart Assoc. 2017 Nov 09; 6(11).
    View in: PubMed
    Score: 0.101
  41. Heterogeneity in national U.S. mortality trends within heart disease subgroups, 2000-2015. BMC Cardiovasc Disord. 2017 07 18; 17(1):192.
    View in: PubMed
    Score: 0.099
  42. Associations of Conventional Echocardiographic Measures with Incident Heart Failure and Mortality: The Chronic Renal Insufficiency Cohort. Clin J Am Soc Nephrol. 2017 01 06; 12(1):60-68.
    View in: PubMed
    Score: 0.094
  43. Different components of blood pressure are associated with increased risk of atherosclerotic cardiovascular disease versus heart failure in advanced chronic kidney disease. Kidney Int. 2016 12; 90(6):1348-1356.
    View in: PubMed
    Score: 0.094
  44. Visit-to-visit variability of blood pressure and death, end-stage renal disease, and cardiovascular events in patients with chronic kidney disease. J Hypertens. 2016 Feb; 34(2):244-52.
    View in: PubMed
    Score: 0.089
  45. Kansas City Cardiomyopathy Questionnaire Score Is Associated With Incident Heart Failure Hospitalization in Patients With Chronic Kidney Disease Without Previously Diagnosed Heart Failure: Chronic Renal Insufficiency Cohort Study. Circ Heart Fail. 2015 Jul; 8(4):702-8.
    View in: PubMed
    Score: 0.085
  46. The complex relationship of race to outcomes in heart failure with preserved ejection fraction. Am J Med. 2015 Jun; 128(6):591-600.
    View in: PubMed
    Score: 0.083
  47. High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study. J Am Soc Nephrol. 2015 Apr; 26(4):946-56.
    View in: PubMed
    Score: 0.081
  48. Arterial stiffness, central pressures, and incident hospitalized heart failure in the chronic renal insufficiency cohort study. Circ Heart Fail. 2014 Sep; 7(5):709-16.
    View in: PubMed
    Score: 0.080
  49. Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2014 May; 167(5):735-42.e2.
    View in: PubMed
    Score: 0.078
  50. Associations between use of the hospitalist model and quality of care and outcomes of older patients hospitalized for heart failure. JACC Heart Fail. 2013 Oct; 1(5):445-53.
    View in: PubMed
    Score: 0.076
  51. Comparison of medication practices in patients with heart failure and preserved versus those with reduced ejection fraction (from the Cardiovascular Research Network [CVRN]). Am J Cardiol. 2013 May 01; 111(9):1324-9.
    View in: PubMed
    Score: 0.073
  52. Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction. J Am Heart Assoc. 2013 Feb 01; 2(1):e005694.
    View in: PubMed
    Score: 0.073
  53. Patterns of comorbidity in older adults with heart failure: the Cardiovascular Research Network PRESERVE study. J Am Geriatr Soc. 2013 Jan; 61(1):26-33.
    View in: PubMed
    Score: 0.072
  54. Epidemiology of peripartum cardiomyopathy: incidence, predictors, and outcomes. Obstet Gynecol. 2011 Sep; 118(3):583-91.
    View in: PubMed
    Score: 0.066
  55. Symptoms characteristic of heart failure among CKD patients without diagnosed heart failure. J Card Fail. 2011 Jan; 17(1):17-23.
    View in: PubMed
    Score: 0.063
  56. Gender and risk of adverse outcomes in heart failure. Am J Cardiol. 2004 Nov 01; 94(9):1147-52.
    View in: PubMed
    Score: 0.041
  57. Breast vascular calcification and risk of coronary heart disease, stroke, and heart failure. J Womens Health (Larchmt). 2004 May; 13(4):381-9; discussion 390-2.
    View in: PubMed
    Score: 0.040
  58. Congestive heart failure with preserved systolic function in a statewide sample of community hospitals. J Card Fail. 2001 Sep; 7(3):221-8.
    View in: PubMed
    Score: 0.033
  59. Association Between Aging of the US Population and Heart Disease Mortality From 2011 to 2017. JAMA Cardiol. 2019 12 01; 4(12):1280-1286.
    View in: PubMed
    Score: 0.029
  60. Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. J Am Heart Assoc. 2016 07 22; 5(7).
    View in: PubMed
    Score: 0.023
  61. Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies. Am J Kidney Dis. 2016 Oct; 68(4):545-553.
    View in: PubMed
    Score: 0.023
  62. Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort. J Am Coll Cardiol. 2015 Jun 30; 65(25):2691-8.
    View in: PubMed
    Score: 0.021
  63. Age and sex differences in long-term outcomes following implantable cardioverter-defibrillator placement in contemporary clinical practice: findings from the Cardiovascular Research Network. J Am Heart Assoc. 2015 Jun 02; 4(6):e002005.
    View in: PubMed
    Score: 0.021
  64. Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry. Am Heart J. 2015 Jul; 170(1):141-8, 148.e1.
    View in: PubMed
    Score: 0.021
  65. Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study. Am J Nephrol. 2014; 40(5):399-407.
    View in: PubMed
    Score: 0.021
  66. Fibroblast growth factor-23 and cardiovascular events in CKD. J Am Soc Nephrol. 2014 Feb; 25(2):349-60.
    View in: PubMed
    Score: 0.019
  67. Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention. JAMA. 2013 May 15; 309(19):2025-34.
    View in: PubMed
    Score: 0.018
  68. Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol. 2012 Oct; 23(10):1725-34.
    View in: PubMed
    Score: 0.018
  69. Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin. Ann Intern Med. 2001 Sep 18; 135(6):393-400.
    View in: PubMed
    Score: 0.008
  70. Prediction of risk for patients with unstable angina. Evid Rep Technol Assess (Summ). 2000 Aug; (31):1-3.
    View in: PubMed
    Score: 0.008

© 2025 Kaiser Permanente